Literature DB >> 9850853

Early stages in the development of human T, natural killer and thymic dendritic cells.

H Spits1, B Blom, A C Jaleco, K Weijer, M C Verschuren, J J van Dongen, M H Heemskerk, P C Res.   

Abstract

T-cell development is initiated when CD34+ pluripotent stem cells or their immediate progeny leave the bone marrow to migrate to the thymus. Upon arrival in the thymus the stem cell progeny is not yet committed to the T-cell lineage as it has the capability to develop into T, natural killer (NK) and dendritic cells (DC). Primitive hematopoietic progenitor cells in the human thymus express CD34 and lack CD1a. When these progenitor cells develop into T cells they traverse a number of checkpoints. One early checkpoint is the induction of T-cell commitment, which correlates with appearance of CD1a and involves the loss of capacity to develop into NK cells and DC and the initiation of T-cell receptor (TCR) gene rearrangements. Basic helix-loop-helix transcription factors play a role in induction of T-cell commitment. CD1a+CD34+ cells develop into CD4+CD8 alpha+ beta+ cells by upregulating first CD4, followed by CD8 alpha and then CD8 beta. Selection for productive TCR beta gene rearrangements (beta selection) likely occurs in the CD4+CD8 alpha+ beta- and CD4+CD8 alpha+ beta+ populations. Although the T and NK-cell lineages are closely related to each other, NK cells can develop independently of the thymus. The fetal thymus is most likely one site of NK-cell development.

Entities:  

Mesh:

Year:  1998        PMID: 9850853     DOI: 10.1111/j.1600-065x.1998.tb01231.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  24 in total

1.  Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors.

Authors:  B Blom; M H Heemskerk; M C Verschuren; J J van Dongen; A P Stegmann; A Q Bakker; F Couwenberg; P C Res; H Spits
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

2.  Evidence for a stepwise program of extrathymic T cell development within the human tonsil.

Authors:  Susan McClory; Tiffany Hughes; Aharon G Freud; Edward L Briercheck; Chelsea Martin; Anthony J Trimboli; Jianhua Yu; Xiaoli Zhang; Gustavo Leone; Gerard Nuovo; Michael A Caligiuri
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

3.  Expression of CD56 antigen in Langerhans cell histiocytosis associated with T-lymphoblastic lymphoma in a same lymph node.

Authors:  Young-Hyeh Ko; Won-Seog Kim; Yoonjung Kim
Journal:  Virchows Arch       Date:  2005-10-14       Impact factor: 4.064

4.  In utero transplantation: Disparate ramifications.

Authors:  John S Pixley; Esmail D Zanjani
Journal:  World J Stem Cells       Date:  2013-04-26       Impact factor: 5.326

5.  Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack.

Authors:  Wei Wang; Huaijian Guo; Jianlin Geng; Xiaodong Zheng; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

6.  Stimulated plasmacytoid dendritic cells impair human T-cell development.

Authors:  Heike Schmidlin; Wendy Dontje; Fedde Groot; Suzanne J Ligthart; Arnaud D Colantonio; Monique E Oud; Esther J Schilder-Tol; Marcel Spaargaren; Hergen Spits; Christel H Uittenbogaart; Bianca Blom
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

7.  Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.

Authors:  Yoshiko Hashii; Tokuko Okuda; Hideaki Ohta; Keiichi Ozono; Junichi Hara
Journal:  Int J Hematol       Date:  2010-02-10       Impact factor: 2.490

8.  Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2.

Authors:  T Ikawa; S Fujimoto; H Kawamoto; Y Katsura; Y Yokota
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 9.  NK cell lymphoma.

Authors:  Kazuo Oshimi
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 10.  Leukemia and lymphoma of natural killer lineage cells.

Authors:  Kazuo Oshimi
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.